OLY1 Stock Overview
Manufactures and sells precision machineries and instruments worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for OLY1 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Olympus Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥13.70 |
| 52 Week High | JP¥17.51 |
| 52 Week Low | JP¥12.62 |
| Beta | 0.62 |
| 1 Month Change | -2.94% |
| 3 Month Change | -9.72% |
| 1 Year Change | 2.70% |
| 3 Year Change | -21.78% |
| 5 Year Change | -19.41% |
| Change since IPO | 180.02% |
Recent News & Updates
Recent updates
Shareholder Returns
| OLY1 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -3.4% | 1.4% | 2.7% |
| 1Y | 2.7% | -2.8% | 17.0% |
Return vs Industry: OLY1 exceeded the German Medical Equipment industry which returned -2.8% over the past year.
Return vs Market: OLY1 underperformed the German Market which returned 17% over the past year.
Price Volatility
| OLY1 volatility | |
|---|---|
| OLY1 Average Weekly Movement | 3.4% |
| Medical Equipment Industry Average Movement | 6.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 11.1% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: OLY1 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: OLY1's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1919 | 28,838 | n/a | www.olympus-global.com |
Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others segments. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopy systems, surgical microscopes, endoscope reprocessors, and maintenance services.
Olympus Corporation Fundamentals Summary
| OLY1 fundamental statistics | |
|---|---|
| Market cap | €16.05b |
| Earnings (TTM) | €603.33m |
| Revenue (TTM) | €6.21b |
26.6x
P/E Ratio2.6x
P/S RatioIs OLY1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OLY1 income statement (TTM) | |
|---|---|
| Revenue | JP¥993.33b |
| Cost of Revenue | JP¥326.29b |
| Gross Profit | JP¥667.04b |
| Other Expenses | JP¥570.61b |
| Earnings | JP¥96.43b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 85.51 |
| Gross Margin | 67.15% |
| Net Profit Margin | 9.71% |
| Debt/Equity Ratio | 31.8% |
How did OLY1 perform over the long term?
See historical performance and comparisonDividends
0.9%
Current Dividend Yield22%
Payout RatioDoes OLY1 pay a reliable dividends?
See OLY1 dividend history and benchmarks| Olympus dividend dates | |
|---|---|
| Ex Dividend Date | Mar 28 2025 |
| Dividend Pay Date | Jun 05 2025 |
| Days until Ex dividend | 39 days |
| Days until Dividend pay date | 108 days |
Does OLY1 pay a reliable dividends?
See OLY1 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/16 16:28 |
| End of Day Share Price | 2025/02/14 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Olympus Corporation is covered by 32 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Warren Lau | Aletheia Analyst Network Limited |
| Masahiro Nakanomyo | Barclays |
| Kunihiko Kanno | BNP Paribas Securities (Asia) |